ABSTRACT
Keywords: MRI, Imaging Sequences, Ultrasound, Mammography, CT, Angiography, Conventional Radiography Published under a CC BY 4.0 license. See also the commentary by Whitman and Vining in this issue.
Subject(s)
Mammography , Radiology , Radiography , Medical Records , ScotlandABSTRACT
This is the second paper on the development and implementation of a universal experimental protocol for transfer and persistence of trace evidence. Here, we present the results of five individual researchers who implemented the universal experimental protocol for the first time. Over 2500 images were collected, computationally analysed and statistically compared. The results were shown to be reliable and consistent under all conditions tested and were used to model the rate of loss of transferred particles over a 7-day timescale. The protocol was additionally extended to include a test of camera settings. The protocol was found to be useable and robust in this preliminary trial paving the way for it to be deployed more widely.
ABSTRACT
Understanding the transfer and persistence of different types of trace evidence between different donor and receiving surfaces under specific conditions, circumstances and alleged competing defence and prosecution hypotheses is a significant need. Acquiring such a knowledge base enables hypothesis testing to be undertaken more readily and with greater confidence. A longstanding goal has been to develop a unified approach to transfer and persistence studies which are fit for purpose but also scalable. Here we propose a low cost, universal experimental protocol using a recognised and well researched proxy material for the development and aggregation of ground truth transfer and persistence data at scale. We also propose and provide the tools to enable the creation of an open source and open access data repository of experimental data to act as a resource for practitioners and researchers in addressing transfer and persistence questions.
ABSTRACT
A method for the quantitative analysis of delta-9-tetrahydrocannabinol (THC, the main active ingredient of cannabis) in whole blood using solid phase extraction and LC/MS/MS has been developed. A bottom-up approach with method validation data was used to evaluate and estimate the measurement uncertainty (MU) of the analytical method. The sources of uncertainty were identified using a cause and effect diagram. The contribution of each uncertainty component was estimated and were combined to derive the overall uncertainty of the analytical method. The combined uncertainty was estimated to be 0.131⯵g/L (<7%). At a 99.7% confidence level, the expanded uncertainty was 0.393⯵g/L for a THC concentration of 2⯵g/L in a whole blood sample. The calculations not only enable the laboratory to quantify the uncertainty associated with a quantitative result, but can also be used to identify the sources of uncertainty and determine if the analytical method can be improved. An open access Measurement Uncertainty Calculator (MUCalc) software has been developed using the method described in this paper.
